Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06884527 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Myopia Control With a Innovative Spectacle Lens - A Cessation Study

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Lead sponsor: [Redacted] to Essilor Internationalv2 Show 6 more changesShow less
    • Trial status: Withheld to Active, Not Recruiting
    • Primary completion date: Oct 2026
    • Study completion date: Nov 2026
    • Start date: Feb 18, 2025
    • Collaborators expanded, about 3 words
    • Study title shortened, about 2 words
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to quantify myopic progression following cessation of a innovative spectacle lenses after 3 years' use.
Trial Details
NCT Number NCT06884527
Lead Sponsor Essilor International
Collaborators: Visioncare Research Ltd.
Conditions
(from sponsor)		 Myopia Progressing
Enrollment 91 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov